HIV
The HIV pipeline: 66 tracked drugs, 25 approved for this indication.
25 approved / phase 410 Phase 33 Phase 2/313 Phase 22 Phase 1/211 Phase 12 preclinical / unstaged
Compare the share prices of listed companies in HIV →
Total attributable cost
$49.2B
$44,569/patient
Drug spend
Not yet sourced
All stages, diagnosed (2024 estimate) · US
The HIV pipeline
Key trial results for every approved and late-stage drug: HIV results by drug.